您当前的位置：
首页 >
文章列表页 >
Clinical application of brain perfusion SPECT/CT imaging with NeuroGamTM software in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease
NUCLEAR CHEMISTRY, RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE | 更新时间：2024-10-25
|

    • Clinical application of brain perfusion SPECT/CT imaging with NeuroGamTM software in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease

    • “The latest research reveals the differences in cerebral blood flow perfusion between subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease, and validates the potential application value of SPECT/CT cerebral blood flow perfusion imaging combined with NeuroGamTM software in the diagnosis of these three diseases.”
    • NUCLEAR TECHNIQUES   Vol. 45, Issue 2, Article number: 020301(2022)

    • DOI：10.11889/j.0253-3219.2022.hjs.45.020301    

      CLC： R817.4

    • Received：02 December 2021，

      Revised：20 December 2021，

      Published：15 February 2022

    移动端阅览

  • LEI Zhe,WU Han,OU Yinghui,et al.Clinical application of brain perfusion SPECT/CT imaging with NeuroGamTM software in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease[J].NUCLEAR TECHNIQUES,2022,45(02):020301-020301. DOI： 10.11889/j.0253-3219.2022.hjs.45.020301.

  •  
  •  

0

Views

105

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

Han WU
Zhe LEI
Xingdang LIU
Jingjing LOU
Xueyuan LIU
Xiuzhe WANG
You YIN
Jing DING

Related Institution

No data
0